Close
Loading...
CONTACT US
:
:
:
Call us at:
:
:
:
Fax:
Email:

ALG2

Products

Loading...

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Background

ALG2, encoded by the ALG2 gene located at human chromosome 9q22.33, is a mannosyltransferase of the glycosyltransferase family. It operates on the cytoplasmic face of the endoplasmic reticulum. The protein comprises 416 amino acids with a molecular weight of approximately 47 kDa. Rather than acting in the Golgi, ALG2 functions in the dolichol-linked oligosaccharide biosynthetic pathway. It catalyzes the addition of mannose residues, forming the mannose-containing N-glycan precursor.

ALG2 is a mannosyltransferase that participates in N-glycan biosynthesis. Its activity adds mannose residues to the dolichol-linked oligosaccharide precursor, an early step in protein N-glycosylation, and it can form both alpha-1,3 and alpha-1,6 linkages. The role of ALG2 in glycan precursor synthesis makes it a useful target for research on N-glycosylation, glycan biosynthesis, and carbohydrate metabolism.

Fig. 1 Structural alignment of wild-type (light blue) and mutant (purple) ALG2 variants modeled with AlphaFold Colab and Blender, highlighting the analyzed change with a red ring. (OA Literature)Fig. 1 Overlap of the wildtype (light blue) and mutant (purple) forms of the studied ALG2 variant, performed using alpha Foldcolab and Blender. The red ring indicates the location of the analyzed change.1

ALG2 Protein Function: Roles in N-Glycan Biosynthesis and Glycosylation

ALG2, encoded by the ALG2 gene, functions as a mannosyltransferase that catalyzes early steps in N-glycan biosynthesis:

  • Mannose Addition: ALG2 adds mannose residues to the dolichol-linked oligosaccharide precursor.
  • Dolichol-Linked Oligosaccharide Biosynthesis: ALG2 operates in the dolichol-linked oligosaccharide pathway, an early stage of N-glycosylation.
  • Alpha-1,3/1,6 Linkages: ALG2 can form both alpha-1,3 and alpha-1,6 mannose linkages.
  • ER Cytoplasmic Face: ALG2 localizes to the cytoplasmic face of the endoplasmic reticulum.
  • Glycosyltransferase Family: ALG2 belongs to the glycosyltransferase family, providing a basis for investigating its catalytic mechanism.

ALG2 Protein Product

Creative Biolabs offers high-quality ALG2 proteins produced using optimized expression systems, including full-length enzyme and isolated catalytic domain variants. As a mannosyltransferase, ALG2 is suitable for studies of N-glycan biosynthesis, enzyme activity, and glycosylation. These proteins can support investigation of dolichol-linked oligosaccharide synthesis. All ALG2 proteins undergo strict quality control to support consistent performance across applicable research platforms.

Custom ALG2 Protein Product

Not finding the protein product you need? Contact us to start your one-stop custom service!

ALG2 Stable Cell Line Product

Creative Biolabs provides custom-engineered ALG2 stable cell lines, including overexpression and blank control models. These cell lines are optimized for studies of N-glycosylation and glycan biosynthesis. Each cell line undergoes stringent validation to ensure stable expression profiles and consistent functional performance in diverse experimental contexts.

ALG2 Stable Cell Line Product

Not finding the stable cell line product you need? Contact us to start your one-stop custom service!

ALG2 Recombinant Antibody Product

High-specificity recombinant antibodies targeting ALG2 are developed using antibody engineering technologies for research applications involving ALG2 expression and localization. These antibodies can be used in studies of ALG2 distribution in the endoplasmic reticulum and may also support characterization of N-glycan biosynthesis in combination with appropriate detection reagents.

ALG2 Recombinant Antibody Product

Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!

Product Features

  • Mannosyltransferase Activity: Supports investigation of mannose addition and N-glycan biosynthesis.
  • ALG2 Specificity: Provides reagents directed against the enzyme for target-focused research applications.
  • Glycosylation Research Compatibility: Optimized reagent series for N-glycan and glycan biosynthesis research workflows.
  • Comprehensive Customization Support: Facilitates end-to-end development of customized proteins, antibodies and stable cell lines to address glycosylation research demands.

Custom ALG2 Research Services

Beyond catalog products, Creative Biolabs offers specialized custom services for ALG2 research:

  • Custom ALG2 Protein Production: Tailored expression of wild-type, mutant, and tagged ALG2 constructs for enzyme activity analysis.
  • Custom Antibody Development: Generation of ALG2-specific antibodies for detection of the enzyme in the endoplasmic reticulum.
  • Stable Cell Line Engineering: Construction of ALG2-modified cell models for glycosylation research.
  • Functional Assay Development: Custom design of mannose addition, enzyme activity, and N-glycan biosynthesis detection workflows.

Frequently Asked Questions (FAQs)

  1. What is the primary function of ALG2?

    ALG2 is a mannosyltransferase that adds mannose residues to the dolichol-linked oligosaccharide precursor, an early step in N-glycan biosynthesis.

  2. Why is ALG2 a significant research target?

    ALG2 catalyzes key steps in N-glycan precursor synthesis, and studying it informs the molecular mechanisms of glycosylation and carbohydrate metabolism.

  3. Are Creative Biolabs' ALG2 products suitable for clinical use?

    No, all ALG2 products and services are strictly for research use only, not intended for clinical diagnosis or treatment.

  4. What types of ALG2 products does Creative Biolabs offer?

    Offerings include full-length ALG2 proteins, custom ALG2 stable cell lines, and ALG2-specific recombinant antibodies for glycosylation research.

  5. What research applications are ALG2 products suitable for?

    ALG2 products are suitable for studies of mannose addition, N-glycan biosynthesis, enzyme activity, and glycosylation.

Reference
  1. Cubilla MA, Sclausero AC, Bisbal M, Asteggiano CG. In vitro cell model to dilucidate the underlying molecular mechanism associated with ophthalmic manifestation of congenital disorders of glycosylation: studying an ALG2-CDG patient. Front Genet. 2025 Oct 21;16:1678103. Under Open Access license CC BY 4.0, without modification. https://doi.org/10.3389/fgene.2025.1678103
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us
Thanksgiving Sale - up to 20% off membrane proteins and stable cell lines
Membrane Proteins Stable Cell Lines
;